MOREPEN LABORATORIES
Back to Income Statement
|
MOREPEN LABORATORIES Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,812 Cr | ₹1,690 Cr | ₹1,418 Cr | ₹1,547 Cr | ₹1,188 Cr |
What is the latest Revenue of MOREPEN LABORATORIES ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹1,812 Cr |
| Mar2025 | ₹1,690 Cr |
| Mar2024 | ₹1,418 Cr |
| Mar2023 | ₹1,547 Cr |
| Mar2022 | ₹1,188 Cr |
How is Revenue of MOREPEN LABORATORIES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,812 Cr | 7.17 | |
| Mar2025 | ₹1,690 Cr | 19.25 | |
| Mar2024 | ₹1,418 Cr | -8.36 | |
| Mar2023 | ₹1,547 Cr | 30.20 | |
| Mar2022 | ₹1,188 Cr | - | |
Compare Revenue of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹5,304.6 Cr | -14.9% | -32.7% | 107.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,963.0 Cr | 2.7% | 1.4% | 4.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹269,451.0 Cr | 4.5% | 6.3% | 50.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,456.0 Cr | 1.8% | -1.3% | 31.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,664.0 Cr | 0.8% | 12.5% | 14.1% | Stock Analytics | |
| CIPLA | ₹113,246.0 Cr | 1.6% | 4.4% | -9.1% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | -14.9% |
-32.7% |
107.8% |
| SENSEX | 7% |
9.6% |
-6.7% |
You may also like the below Video Courses